Diversified Trust CO Vir Biotechnology, Inc. Transaction History
Diversified Trust CO
- $3.55 Billion
- Q2 2025
A detailed history of Diversified Trust CO transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 22,882 shares of VIR stock, worth $131,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,882Holding current value
$131,800% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
257Shares Held
93.5MCall Options Held
257KPut Options Held
261K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$96.1 Million0.99% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$94.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$73.8 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$33 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.68MShares$15.5 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $764M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...